Inventor
Mir Hashim
Inventor
Fremont, CA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61NElectrotherapy23%
C07KPeptides11%
A24FSmokers' requisites1%
A61BDiagnosis1%
A61MDevices for introducing media into, or onto, the body1%
PatentTitleYear
11,026,998Shaped mass composition comprising exenatide202110,953,075Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodies202110,780,266System and method for biphasic transdermal iontophoretic therapeutic agents202010,689,460PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device202010,603,275Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device202010,556,106System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings202010,227,403Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins201910,220,076Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteins201910,098,931Pharmaceutical compositions and methods for fabrication of solid masses comprising immunoglobulins201810,058,595Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodies201810,039,810Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodies20189,987,487Swallowable capsule and method for stimulating incretin production within the intestinal tract20189,849,281System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation20179,775,994'System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings'20179,764,131'System and method for biphasic transdermal iontophoretic delivery of therapeutic agents'20179,643,005'Swallowable capsule and method for stimulating incretin production within the intestinal tract'20179,402,904'Method for transdermal iontophoretic delivery of chelated agents'20169,403,002'Swallowable capsule and method for stimulating incretin production within the intestinal tract'20169,095,503'System and method for biphasic transdermal iontophreotic delivery of therapeutic agents'20159,008,765'System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings'20158,961,492'System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation'20158,958,879'Swallowable capsule and method for stimulating incretin production within the intestinal tract'20158,821,945'Method for transdermal iontophoretic delivery of chelated agents'20148,781,591'Swallowable capsule and method for stimulating incretin production within the intestinal tract'20148,682,440'Swallowable capsule and method for stimulating incretin production within the intestinal tract'20146,911,455'Methods for preparing pharmaceutical formulations'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005Based in Durham, NC, US· patent location history
2014–2021Patents assigned to INCUBE LABS LLC (21)· patent assignee history
2014–2015Patents assigned to HASHIM MIR (4)· patent assignee history
2014–2015Patents assigned to IMRAN MIR (3)· patent assignee history
2014–2016Patents assigned to FE3 MEDICAL INC (2)· patent assignee history
2014–2021Based in Fremont, CA, US· patent location history
2016–2021Patents assigned to RANI THERAPEUTICS LLC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCUBE LABS LLC | 21 | 2014–2021 |
| HASHIM MIRself | 4 | 2014–2015 |
| IMRAN MIR | 3 | 2014–2015 |
| RANI THERAPEUTICS LLC | 3 | 2016–2021 |
| FE3 MEDICAL INC | 2 | 2014–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Fremont, California, US | 25 | 2014–2021 |
| Durham, NC, US | 1 | 2005 |